AbbVie · 11 hours ago
Director, Head of Bioinformatics for Immunology
AbbVie is dedicated to discovering and delivering innovative medicines and solutions that address serious health issues. The Director, Head of Bioinformatics for Immunology is responsible for leading a team to drive data-driven insights for drug discovery and development, particularly in the field of Immunology, while also collaborating across multiple therapeutic areas.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
Accelerate AbbVie’s drug discovery and development pipeline by establishing forward-thinking informatics strategies and executing on results for multiple disease areas within Immunology
Lead a dynamic team of bioinformaticians, and data scientists. Foster a culture of high performance and professional growth, ensuring the team operates at the cutting-edge of scientific research and development
Spearhead innovative computational systems biology initiatives to revolutionize the discovery of therapeutic targets. Integrate insights from genetic, multi-omics, and functional genomics data to drive innovation in therapy development
Oversee the application of AI/ML methods in both Discovery and clinical Development. Enable reverse translation leveraging cross-sectional, multi-modal clinical data analysis and method development
Optimize genetic medicine and biotherapeutics manufacturing capabilities through advanced computational insights and AI/ML applications, enhancing the efficacy and scalability of the next-generation therapeutic approaches
Foster strong collaborations within the Bioinformatics community and across R&D, clinical teams, and other departments to ensure bioinformatic and genetic insights are effectively integrated into AbbVie’s pipeline programs
Cultivate and lead partnerships with academic institutions, biotechnology companies, and technology providers. Drive the evaluation and integration of emerging technologies and methodologies, enhancing team capabilities and keeping AbbVie at the helm of scientific progress
Qualification
Required
PhD. in bioinformatics, statistics, mathematics, computer science, computational biology, genomics, or a related field with 8+ years industry/academic experience
Or master's degree with 15+ years of relevant experience
Proven success of managing, leading, and mentoring interdisciplinary teams in large-scale research environments, demonstrating exceptional management and leadership capabilities
Extensive experience applying AI/ML techniques in drug discovery and development to drive innovation and therapeutic outcomes, with proven results and impact
Deep expertise in transcriptomics and proteomics, encompassing bulk, single-cell, and spatial approaches, and multi-omic integration methodologies
Proficient in genetic analysis techniques, including GWAS, QTL, genetic risk modeling, and multi-omics integration, with a focus on actionable insights
Strong background in target identification, biomarker discovery, and clinical translation, aimed at enhancing therapeutic development processes
Demonstrated ability to collaborate cross-functionally, with experience in working with clinical teams and translating complex computational findings into clinical insights for diverse teams
Adept at articulating complex scientific concepts to non-scientific stakeholders and executive leadership, ensuring clarity and strategic alignment
Benefits
Paid time off (vacation, holidays, sick)
Medical/dental/vision insurance
401(k)
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
H1B Sponsorship
AbbVie has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (214)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Recent News
2025-12-31
Company data provided by crunchbase